Cargando…
Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma
Immunotherapies blocking negative immune checkpoints are now approved for the treatment of a growing number of cancers. However, even in metastatic melanoma, where sustained responses are observed, a significant number of patients still do not respond or display resistance. Increasing evidence indic...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012258/ https://www.ncbi.nlm.nih.gov/pubmed/35432344 http://dx.doi.org/10.3389/fimmu.2022.873116 |